Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio
- PMID: 20364554
Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio
Abstract
Objective: To assess a role of volume-to-creatinine clearance ratio (V/CrCl) and iodine dose-to-creatinine clearance ratio (I-dose/CrCl) in predicting contrast- induced nephropathy (CIN) in diabetic patients undergoing elective cardiac catheterization or percutaneous coronary intervention (PCI).
Background: In diabetic patients undergoing cardiac catheterization or PCI, the incidence of CIN is higher than in non-diabetic patients. High doses of contrast media also increase the likelihood of renal dysfunction. The ratio of the volume of contrast media to creatinine clearance (V/CrCl) and iodine dose-to-creatinine clearance (I-dose/CrCl) has been shown to correlate with the area under the curve of contrast media concentration over time and was used to predict the occurrence of CIN in unselected patients. No study has been conducted specifically in diabetic patients undergoing cardiac catheterization or PCI before.
Material and method: We conducted a prospective, single center study. The V/CrCl and I-dose/CrCl were calculated in diabetic patients undergoing elective cardiac catheterization or PCI. An increase in serum creatinine of > 0.5 mg/dl or > 25% by 7 days from baseline was considered CIN. The incidence of CIN was determined. The predictive value of V/CrCl and I-dose/CrCl for CIN were assessed using multivariable logistic regression.
Results: The total number of patients that had been enrolled in the study was 248; Male 50.8%. The overall incidence of CIN was 5.2%. The mean age for the entire population was 65 +/- 9 years; the mean body mass index was 25.6 +/- 4.0 kg/m2; and the mean creatinine clearance was 60.6 +/- 27.4 ml/min. The mean values of V/CrCl for patients with and without CIN were 3.7 +/- 2.9 and 2.2 +/- 1.7 (p = 0.041). The mean values of I-dose/CrCl for patients with and without CIN were 1.31 +/- 0.94 and 0.82 +/- 0.63 (p = 0.042). The receiver-operator characteristic curve analysis indicated that a V/CrCl ratio of 2.60 and I-dose/CrCl of 0.98 were fair predictors of CIN. After adjusting for other known predictors of CIN, a V/CrCl ratio > or = 2.60 remained the only significant predictor of CIN (Odds ratio 5.8; 95% confidence interval 1.7-19.4, p = 0.005).
Conclusions: A V/CrCl ratio > or = 2.60 was a significant predictor of CIN in diabetic patients undergoing elective cardiac catheterization or PCI.
Similar articles
-
Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention.J Am Coll Cardiol. 2007 Aug 14;50(7):584-90. doi: 10.1016/j.jacc.2007.03.058. Epub 2007 Jul 30. J Am Coll Cardiol. 2007. PMID: 17692741
-
Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.Catheter Cardiovasc Interv. 2012 Jan 1;79(1):70-5. doi: 10.1002/ccd.23048. Epub 2011 Oct 11. Catheter Cardiovasc Interv. 2012. PMID: 21990069
-
Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.J Am Coll Cardiol. 2004 Nov 2;44(9):1780-5. doi: 10.1016/j.jacc.2004.07.043. J Am Coll Cardiol. 2004. PMID: 15519007
-
Contrast Media Volume to Creatinine Clearance Ratio in Predicting Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.Angiology. 2023 Jul;74(6):545-552. doi: 10.1177/00033197221113143. Epub 2022 Jul 10. Angiology. 2023. PMID: 35815550
-
Pravastatin versus simvastatin for prevention of contrast-induced nephropathy.J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):376-9. doi: 10.1177/1074248410394362. Epub 2011 Mar 8. J Cardiovasc Pharmacol Ther. 2011. PMID: 21386035 Review.
Cited by
-
Absolute and relative GFR and contrast medium dose/GFR ratio: cornerstones when predicting the risk of acute kidney injury.Eur Radiol. 2024 Jan;34(1):612-621. doi: 10.1007/s00330-023-09962-w. Epub 2023 Aug 4. Eur Radiol. 2024. PMID: 37540321 Free PMC article.
-
Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?Eur Radiol. 2012 Jun;22(6):1366-71. doi: 10.1007/s00330-011-2371-4. Epub 2012 Feb 4. Eur Radiol. 2012. PMID: 22307815 Review.
-
Urinary neutrophil gelatinase-associated lipocalin predicted to contrast-associated acute kidney injury after planned percutaneous coronary intervention in elderly patients.J Clin Lab Anal. 2022 Dec;36(12):e24757. doi: 10.1002/jcla.24757. Epub 2022 Nov 10. J Clin Lab Anal. 2022. PMID: 36357318 Free PMC article.
-
Safe Limits of Contrast Media for Contrast-Induced Nephropathy: A Multicenter Prospective Cohort Study.Front Med (Lausanne). 2021 Aug 20;8:701062. doi: 10.3389/fmed.2021.701062. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34490295 Free PMC article.
-
Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention.Medicine (Baltimore). 2015 Mar;94(12):e615. doi: 10.1097/MD.0000000000000615. Medicine (Baltimore). 2015. PMID: 25816028 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous